CLASS II ONGOING Drug recall · Reported 21 Feb 2024 · FDA Enforcement Report
Vasopressin in 0.9% Sodium Chloride Sterile Syringe recalled
IntegraDose Compounding Services is recalling Vasopressin in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration:/mL, distributed in Minnesota. The recall was initiated on 22 Jan 2024 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0325-2024
- FDA event ID
- 93940
- Recalling firm
- IntegraDose Compounding Services, Minneapolis, MN
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 22 Jan 2024
- FDA classified
- 15 Feb 2024
- Reported
- 21 Feb 2024
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Injectable & IV Drugs
Timeline
| 22 Jan 2024 | Recall initiated by company | |
| 15 Feb 2024 | Classified by FDA | +24 days |
| 21 Feb 2024 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.
Where it was distributed
MN
Questions about this recall
Why was it recalled?
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Which lots are affected?
Lot #s: 20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024
Where was it sold?
MN
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from IntegraDose Compounding Services
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Vasopressin in 0.9% Sodium Chloride, syringe recalled | IntegraDose Compounding Services | Potency & Assay | Nationwide |
| Drug | CLASS II | fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg recalled | IntegraDose Compounding Services | Potency & Assay | Nationwide |
| Drug | CLASS I | Oxytocin in 0.9% Sodium Chloride for intravenous use recalled | IntegraDose Compounding Services | Potency & Assay | Nationwide |
| Drug | CLASS II | fentaNYL Citrate 2,500 mcg/ in Sterile Water CADD recalled | IntegraDose Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | Vasopressin in 0.9% Sodium Chloride per syringe recalled | IntegraDose Compounding Services | Potency & Assay | MN |
Other Vasopressin recalls
All 5| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Vasopressin, in 0.9% Sodium Chloride Injection per/mL) recalledVasopressin In 0.9% Sodium Chloride | Baxter Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Vasopressin, in 0.9% Sodium Chloride Injection per/mL) recalledVasopressin In 0.9% Sodium Chloride | Baxter Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Vasopressin Injection, USP per mL) Multiple-Dose Vial recalledVasopressin | American Regent | Potency & Assay | Nationwide |
| Drug | CLASS II | Vasostrict (vasopressin in 5% Dextrose) Injection per mL) recalledVasostrict | Par Sterile Products | Potency & Assay | Nationwide |